Condition: Multiple Sclerosis · Sponsor: Central Hospital, Nancy, France
The RelSEP aims to register exhaustively every new case of multiple sclerosis (MS) occuring in Lorraine a French region, and follow up on them for an indefinite duration, registering disease evolution and intercurrent events.
This description comes directly from the study's public registry record.
Francis Guillemin, MD, PHD · francis.guillemin@chru-nancy.fr
Jonathan Epstein, MD, MSc · j.epstein@chru-nancy.fr
Always discuss trial participation with your own doctor first.
| CIC 1433 Épidémiologie clinique, Inserm, Université de Lorraine, CHRU de Nancy | Nancy, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02883335